VINZENZ GRUPPE
     
 

Results from a phase I study of 4-<i>l</i>-[131I]iodo-phenylalanine ([<sup>131</sup>I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).

Tools

Pichler, Josef, Traub-Weidinger, Tatjana, Spiegl, Kurt, Imamovic, Larisa, Braat, Arthur J A T, Snijders, Tom J, Verhoeff, Joost J C, Flamen, Patrick, Tauchmanova, Libuse, Hayward, Colin and Kluge, Andreas (2024) Results from a phase I study of 4-<i>l</i>-[131I]iodo-phenylalanine ([<sup>131</sup>I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1). Neuro-oncology advances, 6 (1). vdae130. ISSN 2632-2498

[thumbnail of Pichler Results from a phase I study IPAX-1 Neurooncol Advanc 2024.pdf]
Preview
 Text
Pichler Results from a phase I study IPAX-1 Neurooncol Advanc 2024.pdf
Download (481kB) | Preview

Abstract

Glioblastoma (GBM), the most common malignant brain tumor, is associated with devastating outcomes. IPAX-1 was a multicenter, open-label, single-arm phase I study to evaluate carrier-added 4-<i>L</i>-[<sup>131</sup>I]iodo-phenylalanine ([<sup>131</sup>I]IPA) plus external radiation therapy (XRT) in recurrent GBM.
Item Type: Fachpublikation (peer reviewed)
Subjects: QZ Pathologie, Onkologie
Divisions: Ordensklinikum Linz Barmherzige Schwestern > Radio-Onkologie und Strahlentherapie
Depositing User: Ivona Vujica
Date Deposited: 18 Nov 2024 07:30
Last Modified: 17 Feb 2025 09:35
URI: https://eprints.vinzenzgruppe.at/id/eprint/10576

Actions (login required)

View Item
View Item